Aldesleukin Terminated Phase 1 / 2 Trials for Recurrent Melanoma / Stage III Melanoma / Stage IV Melanoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01106235Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma